Mainz Register of Patients With Sleep Disorders (MAINZ-SLEEPREG)

September 11, 2022 updated by: Dr. Yaroslav Winter, Johannes Gutenberg University Mainz

Study on Disease Course and Quality of Life in Patients With Sleep Disorders (Mainz Sleep Registry)

Prospective longitudinal observational registry study of all patients with sleep disorders treated in the Mainz Comprehensive Epilepsy and Sleep Medicine Center with the focus on the course of the disease and quality of life.

Study Overview

Detailed Description

Clinical parameters of patients, such as onset of the disease, prior medication, disease severity, which are important for the data analysis also collected retrospectively before the initiation of the registry. Data on the quality of life is collected only prospectively

Study Type

Observational

Enrollment (Anticipated)

500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Rheinland-Pfalz
      • Mainz, Rheinland-Pfalz, Germany, 55131

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 120 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

All patients treated in Mainz Comprehensive Epilepsy and Sleep Medicine Center

Description

Inclusion Criteria:

  • patients with narcolepsy
  • patients with other neurological sleep disorders

Exclusion Criteria:

  • patients aged <18 years
  • patients who cannot provide informed consent and don't have a legal guardian

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patient with narcolepsy treated with vagus nerve stimulation
no interventions, only observation
Patient without narcolepsy treated with vagus nerve stimulation
no interventions, only observation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
European Quality of Life 5 dimensions Index (EQ 5D Index)
Time Frame: 6 months
health-related quality of life measured by EQ5D-Index (European Quality of Life 5 dimensions), rating from 0 (worst possible state) to 1 (best possible state)
6 months
Excessive daytime sleepiness (EDS) as measure by Epworth Sleepiness Scale (ESS) after 3 months (rating from 0 (no sleepiness) to 24 (severe sleepiness))
Time Frame: 3 months
EDS measure by ESS at the follow-up after 3 months
3 months
European Quality of Life 5 dimensions Index (EQ 5D Index)
Time Frame: 3 months
health-related quality of life measured by EQ5D-Index (European Quality of Life 5 dimensions), rating from 0 (worst possible state) to 1 (best possible state)
3 months
Excessive daytime sleepiness (EDS) as measure by Epworth Sleepiness Scale (ESS) after 6 months
Time Frame: 6 months
EDS measure by ESS at the follow-up after 6 months (rating from 0 (no sleepiness) to 24 (severe sleepiness))
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Berlin Social Support Scales (BSSS)
Time Frame: 12 months
Berlin Social Support Scales (BSSS) is used to assess the amount of emotional, informational and instrumental support received by patients: Total scores ranged from 15 to 60, higher scores identify better support
12 months
World Health Organization Quality of Life-BREF (WHOQOL-BREF)
Time Frame: 12 months
World Health Organization Quality of Life-BREF (WHOQOL-BREF), a scale to assess overall quality of life with a range 0-100 (higher scores correspond better quality of life)
12 months
Pittsburgh Sleep Quality Index
Time Frame: 12 months
Pittsburgh Sleep Quality Index (PSQI) is a self-rated questionnaire which assesses sleep quality and disturbances, scoring between 0 and 21 with higher scores corresponding to worse sleep quality
12 months
Multidimensional Fatigue Inventory
Time Frame: 3 months
Multidimensional Fatigue Inventory: 20-item self-report instrument designed to measure fatigue. Measures range from 0-100, representing more severe fatigue at higher scores
3 months
Multidimensional Fatigue Inventory
Time Frame: 6 months
Multidimensional Fatigue Inventory: 20-item self-report instrument designed to measure fatigue. Measures range from 0-100, representing more severe fatigue at higher scores
6 months
Beck Depression Inventory II
Time Frame: 6 months
Beck Depression Inventory II: higher scores correspond to more severe depression (range 0-63)
6 months
Beck Depression Inventory II
Time Frame: 12 months
Beck Depression Inventory II: higher scores correspond to more severe depression (range
12 months
Resilience Scale 13
Time Frame: 6 months
Resilience Scale 13 (short version with 13 questions): 13-66 points correspond with low resilience, 67-72 with moderate and 73-91 with high resilience
6 months
Resilience Scale 13
Time Frame: 12 months
Resilience Scale 13 (short version with 13 questions): 13-66 points correspond with low
12 months
European Quality of Life visual analogue scale (EQ-VAS)
Time Frame: 6 months
European Quality of Life visual analogue scale (EQ-VAS) (ranges from 0 to 100, where 0 is the worst anf 100 the best state)
6 months
European Quality of Life visual analogue scale (EQ-VAS)
Time Frame: 12 months
European Quality of Life visual analogue scale (EQ-VAS) (ranges from 0 to 100, where 0 is the worst anf 100 the best state)
12 months
Ullanlinna Narcolepsy Scale (UNS)
Time Frame: 3 months
scale to identify the burden of narcolepsy
3 months
Ullanlinna Narcolepsy Scale (UNS)
Time Frame: 6 months
scale to identify the burden of narcolepsy
6 months
World Health Organization Quality of Life-BREF (WHOQOL-BREF)
Time Frame: 6 months
World Health Organization Quality of Life-BREF (WHOQOL-BREF), a scale to assess overall quality of life with a range 0-100 (higher scores correspond better quality of life)
6 months
Pittsburgh Sleep Quality Index
Time Frame: 6 months
Pittsburgh Sleep Quality Index (PSQI) is a self-rated questionnaire which assesses sleep quality and disturbances, scoring between 0 and 21 with higher scores corresponding to worse sleep quality
6 months
Berlin Social Support Scales (BSSS)
Time Frame: 6 months
Berlin Social Support Scales (BSSS) is used to assess the amount of emotional, informational and instrumental support received by patients: Total scores ranged from 15 to 60, higher scores identify better support
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2022

Primary Completion (Anticipated)

January 31, 2030

Study Completion (Anticipated)

January 31, 2030

Study Registration Dates

First Submitted

April 4, 2022

First Submitted That Met QC Criteria

April 4, 2022

First Posted (Actual)

April 11, 2022

Study Record Updates

Last Update Posted (Actual)

September 15, 2022

Last Update Submitted That Met QC Criteria

September 11, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sleep Disorder

Clinical Trials on Implantation of vagus nerve stimulation according to clinical indication

3
Subscribe